+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

RNA Targeting Small Molecule Drug Discovery Market Report 2025 - Product Thumbnail Image

RNA Targeting Small Molecule Drug Discovery Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
Non-Injectable Insulin - Product Thumbnail Image

Non-Injectable Insulin

  • Report
  • January 2020
  • 54 Pages
  • Global
From
Rare Diseases Market Report 2024-2034 - Product Thumbnail Image

Rare Diseases Market Report 2024-2034

  • Report
  • May 2024
  • 344 Pages
  • Global
From
Human Insulin Drugs Market in Brazil 2024-2028 - Product Thumbnail Image

Human Insulin Drugs Market in Brazil 2024-2028

  • Report
  • December 2023
  • 142 Pages
  • Brazil
From
From
From
Small Nucleic Acid Therapies Market - Global Forecast 2025-2032 - Product Thumbnail Image

Small Nucleic Acid Therapies Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 196 Pages
  • Global
From
Loading Indicator